Advanced in Toxic Nodular Goiter

Dr. Susan R. Brian

Endocrinology
Cotton-O'neil Clinic Revocable Trust
3520 Sw 6th Ave, 
Topeka, KS 
Offers Telehealth
Advanced in Toxic Nodular Goiter
Cotton-O'neil Clinic Revocable Trust
3520 Sw 6th Ave, 
Topeka, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Susan Brian is an Endocrinologist in Topeka, Kansas. Dr. Brian is rated as an Advanced provider by MediFind in the treatment of Toxic Nodular Goiter. Her top areas of expertise are Anaplastic Thyroid Cancer, Thyroid Cancer, Hyperthyroidism, and Osteoporosis.

Her clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in KS
Hospital Affiliations
Stormont Vail Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

COTTON-O'NEIL CLINIC REVOCABLE TRUST
3520 Sw 6th Ave, Topeka, KS 66606

Additional Areas of Focus

Dr. Brian has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drug: LY3437943
Study Phase: Phase 2
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: November 02, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Advanced in Toxic Nodular Goiter
Dr. Jeffrey P. Fajardo
Endocrinology
Advanced in Toxic Nodular Goiter
Dr. Jeffrey P. Fajardo
Endocrinology

Cotton-O'neil Clinic Revocable Trust

901 Sw Garfield Ave, 
Topeka, KS 
 (1.2 miles away)
785-354-9591
Languages Spoken:
English
See accepted insurances

Jeffrey Fajardo is an Endocrinologist in Topeka, Kansas. Dr. Fajardo is rated as an Advanced provider by MediFind in the treatment of Toxic Nodular Goiter. His top areas of expertise are Thyroid Storm, Toxic Nodular Goiter, Hyperparathyroidism, and Type 2 Diabetes (T2D).

Advanced in Toxic Nodular Goiter
Dr. Mark J. Oertel
Endocrinology
Advanced in Toxic Nodular Goiter
Dr. Mark J. Oertel
Endocrinology

Lawrence Physicians LLC

1130 W 4th St, 3201 Lawrence Endocrinolog, 
Lawrence, KS 
 (25.9 miles away)
785-505-5885
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Oertel is an Endocrinologist in Lawrence, Kansas. Dr. Oertel is rated as an Advanced provider by MediFind in the treatment of Toxic Nodular Goiter. His top areas of expertise are Hyperparathyroidism, Thyroid Storm, Toxic Nodular Goiter, and Graves Disease.

Advanced in Toxic Nodular Goiter
Dr. Andrew J. Green
Endocrinology
Advanced in Toxic Nodular Goiter
Dr. Andrew J. Green
Endocrinology
7450 Kessler St Ste 203, 
Shawnee Mission, KS 
 (56.1 miles away)
913-676-7585
Languages Spoken:
English
See accepted insurances

Andrew Green is an Endocrinologist in Shawnee Mission, Kansas. Dr. Green is rated as an Advanced provider by MediFind in the treatment of Toxic Nodular Goiter. His top areas of expertise are Thyroid Storm, Hypothyroidism, Type 1 Diabetes (T1D), and Type 2 Diabetes (T2D).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brian's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 13 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile